Correlation Between Centessa Pharmaceuticals and XBiotech
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and XBiotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and XBiotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and XBiotech, you can compare the effects of market volatilities on Centessa Pharmaceuticals and XBiotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of XBiotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and XBiotech.
Diversification Opportunities for Centessa Pharmaceuticals and XBiotech
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Centessa and XBiotech is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and XBiotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XBiotech and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with XBiotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XBiotech has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and XBiotech go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and XBiotech
Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 0.98 times more return on investment than XBiotech. However, Centessa Pharmaceuticals PLC is 1.03 times less risky than XBiotech. It trades about 0.09 of its potential returns per unit of risk. XBiotech is currently generating about 0.06 per unit of risk. If you would invest 375.00 in Centessa Pharmaceuticals PLC on September 3, 2024 and sell it today you would earn a total of 1,416 from holding Centessa Pharmaceuticals PLC or generate 377.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. XBiotech
Performance |
| Timeline |
| Centessa Pharmaceuticals |
| XBiotech |
Centessa Pharmaceuticals and XBiotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Centessa Pharmaceuticals and XBiotech
The main advantage of trading using opposite Centessa Pharmaceuticals and XBiotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, XBiotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XBiotech will offset losses from the drop in XBiotech's long position.The idea behind Centessa Pharmaceuticals PLC and XBiotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| XBiotech vs. DiaMedica Therapeutics | XBiotech vs. Lyra Therapeutics | XBiotech vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |